Eli Lilly

2. Eli Lilly

Total Ad Spend: $433.4 million
Television: $367.3 million
Magazine: $43.4 million
Other: $22.7 million

Eli Lilly ($LLY) is getting what it can from erectile dysfunction (ED) drug Cialis and antidepressant Cymbalta while the gettin' is good. It loses patent protection late this year on Cymbalta, which has been generating about $5 billion annually. Lilly also keeps pushing Cialis. A recent study criticized the industry for failing to adhere to voluntary guidelines on when such ads will run, pointing out that ads for Cialis and other ED drugs have crept into family viewing time slots. 

In the spotlight

Cymbalta for pain, $165.8 million
Cialis, $162.8 million
Cymbalta for depression, $77.2 million


 

Eli Lilly
Read more on

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.